the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

View All Categories

Genome-based Drug Discovery Market Research

 

Global Information, Inc. offers market intelligence on every topic in the Genome-based Drug Discovery Market, including, but not limited to latest business trend on: Pharmacogenomics; Lead Optimization; Bioinformatics; ADMET; Genomics; Proteomics; Transcriptomics; Metabonomics; Toxicogenomics.

We offer market research, industry forecasts, and business analysis in the Genome-based Drug Discovery Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 

Reports

Advances in Metabolomics
Published : 2008/03
This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform. ...

Bigpharma Partnering Agreements
Published : 2008/03
The Bigpharma Partnering Agreements provides comprehensive and unprecedented access to the partnering agreements entered into by the worlds leading fifty biopharma companies. ...

Merger and Acquisition Agreements in Biopharma
Published : 2008/02
The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies. The report provides a detail ...

ADME /TOX TECHNOLOGIES - A MARKET INSIGHT REPORT
Published : 2008/01
This market insight report on ADME/Tox Technologies covers both products and services used in the ADME/TOX industry. Predictive technologies analyzed include In vivo, In vitro, and In silico. ...

Antibiotics and Drug Resistance 2008
Published : 2008/01
This report reviews new drug innovation and strategy to combat antibiotic resistance mechanisms. This embraces current research-stage activities, patents published in the last five years, the entire pharmaceutical development pipeline and today' s existin ...

Drug Discovery Technologies
Published : 2007/11
This study examines trends in drug discovery. Drug discovery is an enormous field, and this report focuses on a selection of the major workhorse technologies, including liquid chromatography and mass spectrometry, as well as on newer approaches, such as s ...

RNA Interference Markets
Published : 2007/01
The purpose of this TriMark Publications report is to review the market for RNAi testing equipment and supplies. ...

Stem Cell Markets
Published : 2007/01
The purpose of this TriMark Publications report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. ...

Are Genomic and Proteomic Patents Hindering Drug Development
Published : 2006/11
Sequencing the human genome resulted in a surge of patents for biomarkers, disease correlations, and their commercial uses. ...

Comparative Genomic Hybridization: Current State and Future Directions
Published : 2006/09
Comparative Genomic Hybridization: Current State and Future Directions profiles the major vendors and their CGH product offerings. The report concludes with in-depth interviews with experts in industry and academia, providing authoritative insight into th ...

Big Pharma Embraces Pharmacogenomics - But Are We There Yet?
Published : 2006/08
Pharmacogenomics will revolutionize the drug industry by linking the right drug to the right patient. Several companies and regulatory agencies are leading the charge to implement this approach of developing targeted medicines. ...

U.S. RNAi Markets
Published : 2006/05
The U.S. RNAi markets are rapidly evolving as a growing number of scientists transition their research focus from low-throughput to medium- and high-throughput in one dimension, and from in vitro to in vivo in a second dimension. ...

Microarray Markets
Published : 2006/03
The purpose of this TriMark Publications report is to describe the specific segment of the microarray market aimed at analysis of proteins and DNA. ...

How to Succeed In Personalized Medicine by Using Tools and Technologies Which Companies and Technologies are Profiting From a Favorable Regulatory Environment
Published : 2006/01
The focus of pharmacogenomics is currently selecting targets that are validated from a genetics perspective before looking into the entire genome, attacking attrition early in development (Phase I and II), addressing adverse reactions in Phase III, and su ...

Trends and Emerging Technologies in Drug Discovery
Published : 2005/12
This report provides the information about Trends and Emerging Technologies in Drug Discovery ...

Molecular Diagnostics: New Growth, New Markets
Published : 2005/11
Molecular Diagnostics: New Growth, New Markets highlights current trends in the molecular diagnostic industry and the major prospects and challenges ahead. ...

GENOMICS WORLD MARKETS
Published : 2005/09
Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. ...

U.S. Gene Therapy Markets
Published : 2005/09
Growing Pressure for Results Renews Investor Interest in Gene Therapy ...

Drug Targets from Genomics: Evolving Tools for Discovery
Published : 2005/08
This Report analyzes current and projected revenues from sales of omic technology-based products (reagents and consumables), which in 2004 totaled nearly $1.5 billion. ...

Pharmacogenomics: New Technologies in the Development of Personalized Therapies
Published : 2005/08
Pharmacogenomics and pharmacogenetics will have a major impact on the future of health care. Pharmacogenetics is the study of the genetic basis for individualsEvariable drug responses, and is being applied with increasing frequency at the clinical level. ...

Powering Discovery through Target Evaluation: Moving Beyond the Validation Paradigm
Published : 2005/08
The shift from traditional to genomics-and proteomics-based drug discovery has fundamentally changed the way researchers view the subject of targets. ...

Pharmacodiagnostics: Technologies, Competition, & Market Models
Published : 2005/07
Pharmacodiagnostics: Technologies, Competition, and Market Models examines the reasons why the business environment of pharmaceuticals is changing in favor of pharmacodiagnostics, and describes market models that are likely to emerge as the pharmaceutical ...

Single Nucleotide Polymorphisms (SNPs) Detection Technology Markets in Europe
Published : 2005/07
Though some success stories are slowly emerging about utility of SNPs in drug discovery there is now a greater need for additional validation and proof of concept studies. The clinical significance of how the use of SNPs will ultimately affect clinical ou ...

The Market for SNP Genotyping Products & Services
Published : 2005/07
The Market for SNP Genotyping Products & Services details researchers' experimental parameters, current and future levels of sample throughput ...

Genomics and Proteomics Markets in Australia
Published : 2005/06
Extensive research in genomics and proteomics is promising cures for previously untreatable diseases. ...

Model Organisms in Drug Discovery and Development: An Industry Analysis
Published : 2005/06
The Report provides comparisons of the various model organisms being deployed currently by the pharmaceutical and biotechnology companies ...

Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
Published : 2005/04
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi, is a new report which provides an in-depth analysis of three technological innovations that are being heralded to revolutionize the drug d ...

Biomarkers in Clinical Development: Implications for Personalized Medicine and Streamlining R&D
Published : 2005/03
The cost to discover and develop a drug is increasing dramatically; however, the number approved new drug products on the decline. ...

Solving Drug Discovery with Metabolomics and Metabonomics: New Aspects of the "Omic" Revolution
Published : 2005/02
This Report will analyze the biochemical nature of metabolomics, the technologies behind metabolomics, metabonomics related approaches, and the appropriate market potentials. ...

Drug Discovery--European Advances in Genomics and Proteomics
Published : 2004/12
The European Union (EU) has become a popular hub for advanced research into genomics and proteomics. ...

Toxicogenomics and Predictive Toxicology: Market and Business Outlook
Published : 2004/12
Toxicogenomics and Predictive Toxicology: Market and Business Outlook addresses the significant need and potential for predictive toxicology in drug development. ...

DNA Sequencing and PCR markets
Published : 2004/11
The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. ...

Membrane Technology for Biopharmaceuticals
Published : 2004/11
This BCC technical market report provides an in-depth analysis of the market for membrane technology across a range of life science/biotech applications including gene and protein analysis. ...

Strategic Analysis of Biomarkers in Clinical Trials
Published : 2004/10
Biomarkers to Play a Key Role in Tackling Failure Rates in Clinical Trials ...

The Future of Personalized Medicine: The impact of proteomics on drug discovery and clinical trial design
Published : 2004/10
'Personalized Medicine: The impact of proteomics on drug discovery and clinical trial design' is a management report that analyses how proteomics will streamline drug development and lead to the more cost-effective development of niche personalized produc ...

Fluorescent Proteins Technologies, Applications, and Opportunities for Drug Discovery
Published : 2004/08
Fluorescent proteins are fast providing novel insights into compound-induced responses in drug discovery. This is taking place from two key vantage points, namely, in real time and in living systems. ...

Chemical Genomics Commercial Applications in Drug Discovery and Development
Published : 2004/07
D&MD's Chemical Genomics Report provides an in-depth analysis of the promising market for chemical genomics and chemogenomics. ...

Monoclonal Antibodies in Cancer Therapy: Emerging Products and Markets
Published : 2004/06
This study reviews market data for the years 2001 to the present and forecasts the market to 2008, including Kaloramafs estimates of the competitive market share in 2008 based on the current pipeline and likely market conditions. ...

Therapeutics from Transgenic Sources
Published : 2004/06
This important BCC report provides insight into new technologies for producing drugs, biologics, cells, tissues and organs from transgenic animals and for producing biopharmaceuticals from transgenic plants. ...

Clinical Genomics: The Impact of Genomic Technology on Clinical Trials and Medical Practice
Published : 2004/05
This report assesses the challenges and future prospects for incorporating genomics technologies into standard clinical practice. ...

Markets in Geriatric Medicine Volume III: Cardiovascular Disease
Published : 2004/03
The report will look at the demographics of the aging United States population, the expected incidence and prevalence of cardiovascular disease of different types, and the United States markets for these therapeutics, currently estimated at over $6.1 bill ...

The $1,000 Human Genome - Implications for Life Science, Healthcare, and IT
Published : 2004/03
This IDC study incorporates survey data and in-depth interviews from thought leaders in the fields of genomics, genetics, bioinformatics, and technology development. ...

Orphan Drugs: Success Stories and Market Strategies
Published : 2004/02
This report provides an in-depth look at the life stories of drugs with orphan disease designation(s) that had sales in excess of $200 million in 2002. ...

Lead Optimization A Reinvention of the Process
Published : 2003/11
This report examines in detail how to successfully integrate intelligent lead optimization library design and synthesis, advanced screening technologies, and early involvement of in vivo testing. ...

Successful Pharmacogenomics Business Models
Published : 2003/11
This report provides a theoretical framework to evaluate pharmacogenomics initiatives within pharmaceutical companies. ...

The Market for Lead Optimization Tools and Services: Applying the new "-omics" to enhance drug discovery
Published : 2003/10
In this report, Kalorama focuses on one of the trickiest yet also most promising areas: the interface between discovery and development known as lead optimization. ...

Ion Channels Technology Advances Driving Commercial Opportunities
Published : 2003/09
This is the only publication focused solely on the commercial interest in ion channels technologies. This Report is essential reading for those decision-makers in the pharmaceutical, biotechnology, and drug discovery industries. ...

Post-Genomic Target Validation: Next-Generation Approaches and Tools for Optimizing Target Selection
Published : 2003/09
After decades of focusing on a few hundred relatively well-characterized therapeutic targets, drug developers are now finding that the genomics revolution has presented them with the opposite dilemma: ...

The Therapeutic Proteins Outlook To 2007: An analysis of leading products and late-stage pipeline developments
Published : 2003/08
The management report, 'The Therapeutic Proteins Outlook to 2007: An analysis of leading products and late-stage pipeline developments' is a timely global market assessment of the ten major therapeutic protein classes. ...

Drug Discovery Industry Review
Published : 2003/07
Drug discovery technology involves innumerable assays to determine the molecular affinities and potential toxic effects of drug candidates. In the past decade, through the application of combinatorial chemistry and genomics, the number of drug candidates ...


Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.